# Teitur Trophics announces successful results from Phase I - GlobeNewswire

*Источник: GlobeNewswire*
*Дата: 2026-09-10*
*Язык: en*

<a href="https://news.google.com/rss/articles/CBMiowJBVV95cUxQeUtyVDI4ajEzYUdfV2dvMnNKZ2FDMXQ0SHVFVFF4Y3QxbEVMNGs2eU5LcXV3Zy1NUmRsbl9VQ0cwdGR4WTVzMmNVUTAzTThra2NZNTh3VThnNTllcWxrV25qT2l1ZUJmS3FFaDlHT3U2S1Axc1lGU0c3aml3czJ6WEFYNUZYbnNPaVc3eHNXbVpfLTFmek03ZmpFNzc2ckRoOC1EcTB0VUxOc2dia2FSekdTR05vMFpyYWUyaVkyZlNGRHM2dUN4NEZRSUJOazlqUlFDUWZkdnFrV1hzbUUySzF5OVdRQVB6Ni1qWTRTbV8ybmM1b3NqV1E0eTJ0X2VGamVkUmRsMFZrR1U4VDN1Tzh1UmFXOVdrckNMUnpUdUt4c2s?oc=5" target="_blank">Teitur Trophics announces successful results from Phase I</a>&nbsp;&nbsp;<font color="#6f6f6f">GlobeNewswire</font>

[Оригинал](https://www.globenewswire.com/news-release/2026/09/10/3359221/0/en/teitur-trophics-announces-successful-results-from-phase-i-clinical-trial-of-first-in-class-parkinson-s-disease-peptide-tt-p34.html)